Venture Capital & Pre-IPO Insights

Groq 2.0 – a relaunch with a rating half that of last year

Groq closed a $350 million Series A at a $3.5 billion valuation. The round is being led by investment firm Disruptive, with NVIDIA also planning to participate

The hyperscalers' backlog grew 2.5 times in a year to $1.7 trillion

Microsoft, Alphabet, and Amazon closed the June 30 quarter with combined contractual obligations of $1.69 trillion

Crusoe Discusses IPO, Adding Second Path to Capital to Private Round

Crusoe is in talks with JPMorgan, Goldman Sachs, Morgan Stanley, and Bank of America about a possible public offering, Axios reported, citing sources

Lovable and Cerebras Systems: A Partnership for Speed

The company is now offloading latency-sensitive tasks to Cerebras' inference infrastructure

Lovable's AI agent errors are now covered by Lloyd's of London

Lovable is the first AI development platform to achieve AIUC-1 certification, a security standard specifically written for AI agents

Positron AI's new deal will reach $1 billion to $5 billion in six months

We are pleased to introduce Positron to our investors. The company designs chips for inference—the processing of already trained AI models.

Lovable doubles valuation to $13.3 billion

Swedish vibe coding platform Lovable raised $400 million in a Series C

Form Energy has raised $750 million and is preparing for an IPO. The sale closes on Monday

Yesterday, August 12th, our portfolio project, Form Energy, closed a $750 million Series G round

Crusoe to Deploy 10 Modular Data Centers in Texas

Energy Vault has begun construction on the Snyder AI campus in Snyder, Texas. The company is purchasing 10 Crusoe Spark modular data centers from Crusoe and ...

Revolut received two banking licenses in three weeks

Two regulatory perimeters on two continents in three weeks, with a customer base of 75 million

Mercor is discussing a new round at a $20 billion valuation

AI startup Mercor is in talks to raise capital at a $20 billion valuation, according to Bloomberg

Why 40% of US Doctors Already Work with OpenEvidence